This activity will discuss current clinical scenarios in prostate cancer with an expert panel discussing decision points starting from a patient case but expanding to include audience responses, the panel's opinion, and finally discussing the evidence and guidelines for each situation.

Patient Reported Outcomes (PROs) are often minimized as bulky processes that require time for patients to fill out and impose further administrative burdens on providers. This is not necessarily so.

This course pulls together international experts in the use of hypofractionation for head and neck cancer, using a case based approach to illustrate common clinical scenarios.

This journal activity provides practitioners with the knowledge about the treatment efficacy and treatment cost of conventional vs altered fractionation regimens for breast cancer.